Waitlist Controlled Comparison of Cognitive-behavioral vs. Mindfulness-based Online-treatments for Women With Low Sexual Desire
MiSELF
Randomized-controlled Comparison of Two Online-interventions: How Effective Are Cognitive-behavioral and Mindfulness-based Sexual Therapy in Improving Sexual Desire in Women With Hypoactive Sexual Desire Disorder?
1 other identifier
interventional
266
1 country
1
Brief Summary
Problems with sexual function are common and distressing. The most frequent sexual difficulty in women is a lack of sexual desire with a prevalence of 20-30%. When low sexual desire is experienced over several months and causes significant personal distress, a sexual dysfunction can be diagnosed (ICD-10: Hypoactive Sexual Desire Disorder: HSDD). A distressing lack of desire is reported by 6% of sexually active women. Psychological interventions are the treatment of choice for women with HSDD. Promising treatment approaches include cognitive-behavioral and mindfulness-based interventions. A recent meta-analysis also showed that Internet-delivered programs are a valid alternative to face-to-face treatments. Aim of this project to assess the effectivity of two eight-week online-programs consisting of cognitive-behavioral (COPE) and mindfulness-based (MIND) interventions for women with HSDD. Both treatments will be compared to a waitlist-control group. For this project, two well-established group-treatment manuals will be translated into German and adapted to a multimedia online-environment. All participants will be guided through the programs by well-qualified eCoaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2018
CompletedStudy Start
First participant enrolled
December 18, 2018
CompletedFirst Posted
Study publicly available on registry
December 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 16, 2022
CompletedMarch 29, 2023
March 1, 2023
3.7 years
December 18, 2018
March 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sexual Interest and Desire Inventory Female (SIDI-F)
The SIDI-F is a clinician-rated instrument consisting of 13 items designed to assess HSDD severity in women. A self-report version, modified for the use in partnered and unpartnered women will be applied.
at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
Secondary Outcomes (1)
Female Sexual Distress Scale Revised (FSDS-R)
at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
Other Outcomes (15)
Desire subscale of the Female Sexual Function Index
at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
Patient Health Questionnaire 9 (PHQ-9)
at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
Generalized Anxiety Disorder 7 (GAD-7)
at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
- +12 more other outcomes
Study Arms (3)
Cognitive-behavioral treatment
EXPERIMENTALCOPE-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and cognitive-behavioral interventions (e.g., thought diaries, challenging of maladaptive thought patterns, behavioral analysis). Participants are encouraged to practice exercises between sessions.
Mindfulness-based treatment
EXPERIMENTALMIND-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and mindfulness-based exercises (e.g., breathing meditation, body scan, sitting meditation).
Waitlist
NO INTERVENTIONParticipants will receive no immediate treatment but will be able to choose either MIND or COPE after a six months waiting period.
Interventions
COPE-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and cognitive-behavioral interventions (e.g., thought diaries, challenging of maladaptive thought patterns, behavioral analysis). Participants are encouraged to practice exercises between sessions.
MIND-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and mindfulness-based exercises (e.g., breathing meditation, body scan, sitting meditation).
Eligibility Criteria
You may qualify if:
- years or older
- female gender
- able to read, write and speak German
- Meet criteria of ICD-10 criteria of Hypoactive Sexual Desire Disorder (established via online-screening and telephone interview)
- Experience significant sexuality-related personal distress (established via online-screening and telephone interview)
You may not qualify if:
- currently pregnant
- ongoing medical or psychological treatment for low desire or other sexual dysfunctions or plans to enter such treatment (e.g., in-person sexual therapy, couples therapy) during study participation
- suicide ideation (established via telephone interview)
- currently experiencing significant symptoms of a mental disorder that might interfere with study participation (e.g., Eating Disorders, Obsessive-Compulsive Disorder, Posttraumatic Stress Disorder, Major Depression, Bipolar Disorder) as established via telephone interview
- currently experiencing significant symptoms of a physical condition that might interfere with study participation (e.g., cancer, multiple sclerosis) as established via telephone interview
- current Substance-Abuse Disorder
- current or lifetime Psychotic Disorder
- significant relationship discord or violence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruhr University of Bochumlead
- Friedrich-Alexander-Universität Erlangen-Nürnbergcollaborator
- University of British Columbiacollaborator
Study Sites (1)
Ruhr University Bochum
Bochum, North Rhine-Westphalia, 44787, Germany
Related Publications (2)
Velten J, Hirschfeld G, Meyers M, Margraf J. Results of a randomized waitlist-controlled trial of online cognitive behavioral sex therapy and online mindfulness-based sex therapy for hypoactive sexual desire dysfunction in women. J Consult Clin Psychol. 2024 Nov;92(11):742-755. doi: 10.1037/ccp0000922. Epub 2024 Oct 24.
PMID: 39446648DERIVEDMeyers M, Margraf J, Velten J. Psychological Treatment of Low Sexual Desire in Women: Protocol for a Randomized, Waitlist-Controlled Trial of Internet-Based Cognitive Behavioral and Mindfulness-Based Treatments. JMIR Res Protoc. 2020 Sep 29;9(9):e20326. doi: 10.2196/20326.
PMID: 32990248DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julia Velten, PhD
Ruhr University Bochum
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Research Associate
Study Record Dates
First Submitted
December 18, 2018
First Posted
December 19, 2018
Study Start
December 18, 2018
Primary Completion
September 16, 2022
Study Completion
September 16, 2022
Last Updated
March 29, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
IPD data of accepted publications will be published open access on the respective Journal's website or on the Open Science Framework.